Ace the RFP Roadmap Challenge 2026 – Navigate Your Way to Proposal Success!

In Preliminary Pricing, the key idea is to ensure that there is a representative level of clinical input guiding the pricing assumptions. Requiring 50% medical participation keeps the pricing grounded in actual medical perspectives and utilization patterns, rather than being driven solely by administrative or non-clinical views. This threshold helps ensure the proposed prices reflect real clinical needs and workflows, making the preliminary numbers more credible for later stages.

An exception can be approved to allow less than half of participants to be medically involved when circumstances justify it, preserving flexibility without sacrificing the integrity of the process. Higher thresholds, like three-quarters or all participation, would add rigidity at this early stage and are not required here, while zero medical participation would defeat the purpose of having medical input in the pricing.